+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zometa"

From
From
From
Research Report on China's Zoledronic Acid Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Zoledronic Acid Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Zometa Concentrate - API Insight, 2022 - Product Thumbnail Image

Zometa Concentrate - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zometa- Drug Insight, 2019 - Product Thumbnail Image

Zometa- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Zometa is a brand of oncology drug used to treat bone metastases and other bone diseases. It is a bisphosphonate, a type of drug that helps to reduce the risk of fractures and other bone complications in cancer patients. Zometa is administered intravenously and works by inhibiting the activity of osteoclasts, cells that break down bone tissue. It is used to treat a variety of cancers, including breast, prostate, and lung cancer. Zometa is a widely used drug in the oncology market, and is often prescribed in combination with other treatments. It is generally well-tolerated, with few side effects. Common side effects include nausea, vomiting, and constipation. The oncology market is highly competitive, with many companies offering similar products. Some of the major players in the Zometa market include Novartis, Amgen, and Merck. Other companies, such as Teva Pharmaceuticals and Pfizer, also offer generic versions of the drug. Show Less Read more